Salignostics is developing saliva-based rapid diagnostic tests (RDTs) utilizing a lateral flow immunoassay platform.

The approach qualifies saliva for a variety of RDTs, including for pregnancy, ovulation, H. pylori, and malaria.The companys platform comprises a toolbox of technologies that amplify saliva as a detectable body fluid by overcoming different chemical and biological saliva-related obstacles.

Implementation of these technologies transforms saliva from a nondetectable to a detectable body fluid.Salignostics is developing the Salistick, a rapid saliva-based pregnancy test; the MalKit, a saliva-based RDT for malaria; and the PyloriKit, a saliva-based RDT for Helicobacter pylori infection.